MindWalk Holdings (HYFT) Gross Margin (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Gross Margin of 0.0% for Q2 2026, down 6389.0% year-over-year from 0.0% in Q2 2025, and down 100.0% quarter-over-quarter from 59.26% in Q1 2026.
MindWalk Holdings (HYFT) Gross Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Gross Margin for 7 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.
- In Q2 2026, Gross Margin fell 6389.0% year-over-year to 0.0%; the TTM figure through Apr 2026 stood at 32.14% (down 2555.0% YoY), while the FY2026 annual figure was 58.8%, up 487.0% from the prior year.
- Gross Margin fell to 0.0% in Q2 2026 per HYFT's latest filing, from 59.26% in the prior quarter.
- Across five years, Gross Margin topped out at 73.98% in Q1 2022 and bottomed at 0.0% in Q2 2026.
- Historically, Gross Margin has averaged 50.92% across 5 years, with a median of 55.46% in 2022.
- Annual changes were most pronounced in 2024 — Gross Margin surged 5105 bps — and 2026, when it plunged 6389 bps.
- MindWalk Holdings' Gross Margin stood at 53.61% in 2022, then slumped by 100 bps to 0.05% in 2023, then soared by 106289 bps to 51.1% in 2024, then grew by 26 bps to 64.55% in 2025, then sank by 100 bps to 0.0% in 2026.
- Business Quant data shows HYFT's Gross Margin at 0.0% in Q2 2026, 59.26% in Q1 2026, and 64.55% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 80.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 0.00% |
| Jan 31, 2026 | 59.26% |
| Oct 31, 2025 | 64.55% |
| Jul 31, 2025 | 48.31% |
| Apr 30, 2025 | 63.89% |
| Jan 31, 2025 | 64.55% |
| Oct 31, 2024 | 51.10% |
| Jul 31, 2024 | 40.84% |
| Apr 30, 2024 | 62.38% |
| Jan 31, 2024 | 51.39% |
| Oct 31, 2023 | 0.05% |
| Jul 31, 2023 | 49.14% |
| Apr 30, 2023 | 59.44% |
| Jan 31, 2023 | 57.32% |
| Oct 31, 2022 | 53.61% |
| Jul 31, 2022 | 53.44% |
| Apr 30, 2022 | 63.29% |
| Jan 31, 2022 | 73.98% |
| Oct 31, 2021 | 58.65% |
| Jul 31, 2021 | 54.62% |